Trials / Conditions / Factor VIII Deficiency

Factor VIII Deficiency

9 registered clinical trials studyying Factor VIII Deficiency — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy NCT06941870	Sanofi	Phase 4
Completed	Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A NCT06020456	Groupe Maladies hémorragiques de Bretagne	—
Recruiting	ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628	American Thrombosis and Hemostasis Network	—
Completed	A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand NCT04161495	Bioverativ, a Sanofi company	Phase 3
Completed	Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy NCT03876301	Spark Therapeutics, Inc.	—
Completed	Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT® NCT03006965	Spanish Society of Thrombosis and Haemostasis	—
Terminated	A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipun NCT02402829	Children's Mercy Hospital Kansas City	—
Recruiting	The European Paediatric Network for Haemophilia Management ( PedNet Registry) NCT02979119	PedNet Haemophilia Research Foundation	—
Completed	An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia NCT02199717	The Hospital for Sick Children	—